Filing Details
- Accession Number:
- 0001312548-12-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-19 18:52:43
- Reporting Period:
- 2012-12-17
- Filing Date:
- 2012-12-19
- Accepted Time:
- 2012-12-19 18:52:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1323885 | Atricure Inc. | ATRC | Surgical & Medical Instruments & Apparatus (3841) | 341940305 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1312548 | Discovery Group I, Llc | 191 N. Wacker Drive Suite 1685 Chicago IL 60606 | No | No | Yes | No | |
| 1323510 | R Michael Murphy | C/O Discovery Group I, Llc 191 N. Wacker Drive Suite 1685 Chicago IL 60606 | No | No | Yes | No | |
| 1323511 | J Daniel Donoghue | C/O Discovery Group I, Llc 191 N. Wacker Drive Suite 1685 Chicago IL 60606 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-12-17 | 10,000 | $6.53 | 1,621,334 | No | 4 | S | Indirect | By Pleiades Investment Partners - D |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Pleiades Investment Partners - D |
Footnotes
- Discovery Group I, LLC is an investment manager for Pleiades Investment Partners - D, L.P., which is a discretionary client of the reporting person, that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- This transaction was executed in multiple trades at prices ranging from $6.50 - $6.57. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
Billionaire Hedge Funds
